Evidence map›Paper›PMID 33824855›Full record

ArticleAfrican journal of laboratory medicine2021

An oral history of medical laboratory development in francophone West African countries.

Winny Koster, Albert G Ndione, Mourfou Adama, Ibrehima Guindo, Iyane Sow, Souleymane Diallo, Jean Sakandé, Pascale Ondoa

Abstract read
In one paragraph

Article in African journal of laboratory medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Winny KosterAmsterdam Institute for Global Health and Development, Amsterdam, the Netherlands.ORCID https://orcid.org/0000-0002-5365-6412
Albert G NdioneInstitut de Recherche pour le Développement (IRD), TransVIHMI, CRCF-Hôpital Fann, Dakar, Senegal.ORCID https://orcid.org/0000-0002-6351-0046
Mourfou AdamaCentre National de Lutte Anti Tuberculeuse (CNLAT), Laboratoire National de Référence des Mycobactéries, Ouagadougou, Burkina Faso.ORCID https://orcid.org/0000-0002-9370-0633
Ibrehima GuindoInstitut National de Recherche en Santé Publique, Bamako, Mali.ORCID https://orcid.org/0000-0003-3130-4763
Iyane SowDirectorate of Laboratory services, Ministry of Public Health and Social Welfare, Dakar, Senegal.ORCID https://orcid.org/0000-0002-3587-3034
Souleymane DialloCentre d'Infectiologie Charles Mérieux, Bamako, Mali.ORCID https://orcid.org/0000-0002-6463-5588
Jean SakandéFondation Mérieux, Ouagadougou, Burkina Faso.ORCID https://orcid.org/0000-0002-7872-0222
Pascale OndoaAmsterdam Institute for Global Health and Development, Amsterdam, the Netherlands.ORCID https://orcid.org/0000-0002-2700-9000

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUnderdeveloped and underused medical laboratories in sub-Saharan Africa negatively affect the diagnosis and appropriate treatment of ailments.

objectiveWe identified political, disease-related and socio-economic factors that have shaped the laboratory sector in Senegal, Mali and Burkina Faso to inform laboratory-strengthening programmes.

methodsWe searched peer-reviewed and grey literature from February 2015 to December 2018 on laboratory and health systems development from colonial times to the present and conducted in-depth interviews with 73 key informants involved in (inter)national health or laboratory policy, organisation, practice or training. This article depended on the key informants' accounts due to the paucity of literature on laboratory development in francophone West African countries. Literature and interview findings were triangulated and are presented chronologically.

resultsUntil around 1990 there were a few disease-specific research laboratories; only the larger hospitals and district health facilities housed a rudimentary laboratory. The 1990s brought the advent of donor-dictated, vertical, endemic and epidemic disease programmes and laboratories. Despite decentralising from the national level to the regional and district levels, these vertical laboratory programmes biased national health resource allocation deleteriously neglecting the development of the horizontal, general-health laboratory. After the year 2000, the general-health laboratory system received more attention when, influenced by the World Health Organization, national networks and (sub-)directorates of laboratories were installed.

conclusionTo advance national general healthcare, as opposed to disease-specific healthcare, national laboratory directors and experts in general laboratory development should be consulted when national policies are made with potential laboratory donors.

Indexed as

Burkina FasoMalimedical laboratoryoral historySenegal

Identifiers

PMID33824855
PMCPMC8008026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.